Immunologically Inert Nanostructures as Selective Therapeutic Tools in Inflammatory Diseases

The current therapies based on immunosuppressant or new biologic drugs often show some limitations in term of efficacy and applicability, mainly because of their inadequate targeting and of unwanted adverse reactions they generate. To overcome these inherent problems, in the last decades, innovative nanocarriers have been developed to encapsulate active molecules and offer novel promising strategies to efficiently modulate the immune system. This review provides an overview of how it is possible, exploiting the favorable features of nanocarriers, especially with regard to their immunogenicity, to improve the bioavailability of novel drugs that selectively target immune cells in the context of autoimmune disorders and inflammatory diseases. A focus is made on nanoparticles that selectively target neutrophils in inflammatory pathologies.

[1]  N. Voelcker,et al.  Inducing immune tolerance with dendritic cell-targeting nanomedicines , 2020, Nature Nanotechnology.

[2]  M. Vallet‐Regí,et al.  Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles , 2020, International journal of molecular sciences.

[3]  Leitgeb Maja,et al.  Sustainable technologies for liposome preparation , 2020 .

[4]  Wonhwa Lee,et al.  Bioinspired DNase‐I‐Coated Melanin‐Like Nanospheres for Modulation of Infection‐Associated NETosis Dysregulation , 2020, Advanced science.

[5]  M. Vallet‐Regí,et al.  Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines , 2020, Pharmaceutics.

[6]  J. Lovell,et al.  Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment , 2020, International journal of molecular sciences.

[7]  Aiping Lu,et al.  Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment , 2020, Molecules.

[8]  P. Couvreur,et al.  Advanced nanomedicines for the treatment of inflammatory diseases , 2020, Advanced Drug Delivery Reviews.

[9]  L. Shea,et al.  Neutrophils preferentially phagocytose elongated particles—An opportunity for selective targeting in acute inflammatory diseases , 2020, Science Advances.

[10]  Sarkar Siddique,et al.  Gold Nanoparticles for Drug Delivery and Cancer Therapy , 2020, Applied Sciences.

[11]  Bin Bai,et al.  Efficient Delivery of Triptolide Plus a miR-30-5p Inhibitor Through the Use of Near Infrared Laser Responsive or CADY Modified MSNs for Efficacy in Rheumatoid Arthritis Therapeutics , 2020, Frontiers in Bioengineering and Biotechnology.

[12]  Meghna Talekar,et al.  Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes , 2020, The Journal of Immunology.

[13]  Hong Yang,et al.  Manipulation of macrophage polarization by peptide-coated gold nanoparticles and its protective effects on acute lung injury , 2020, Journal of Nanobiotechnology.

[14]  D. Svergun,et al.  Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins , 2020, Pharmaceutics.

[15]  A. Deshpande,et al.  Mannosylated nanocarriers mediated site-specific drug delivery for the treatment of cancer and other infectious diseases: A state of the art review. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[16]  V. Puntes,et al.  Gold Nanoparticles Modulate BCG-Induced Innate Immune Memory in Human Monocytes by Shifting the Memory Response towards Tolerance , 2020, Cells.

[17]  L. De Cola,et al.  Breaking with Light: Stimuli-Responsive Mesoporous Organosilica Particles , 2020 .

[18]  T. Etrych,et al.  Targeted Polymer-Based Probes for Fluorescence Guided Visualization and Potential Surgery of EGFR-Positive Head-and-Neck Tumors , 2020, Pharmaceutics.

[19]  I. Lynch,et al.  Corona of Thorns: The Surface Chemistry-Mediated Protein Corona Perturbs the Recognition and Immune Response of Macrophage. , 2019, ACS applied materials & interfaces.

[20]  C. Zhang,et al.  Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke , 2019, Science Advances.

[21]  J. Rossjohn,et al.  PD-L1 and calcitriol dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease. , 2019, JCI insight.

[22]  C. Dinarello The IL-1 family of cytokines and receptors in rheumatic diseases , 2019, Nature Reviews Rheumatology.

[23]  W. Chan,et al.  Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity. , 2019, Nano letters.

[24]  A. David,et al.  Near-infrared fluorescent (NIRF) activated polymeric probe for imaging intraluminal colorectal cancer tumors. , 2019, Biomacromolecules.

[25]  Qi Huang,et al.  Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation , 2019, Front. Immunol..

[26]  S. Sahi,et al.  Fabrication of innocuous gold nanoparticles using plant cells in culture , 2019, Scientific Reports.

[27]  B. Baradaran,et al.  Liposome and immune system interplay: Challenges and potentials. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Xingjun Zhu,et al.  Non-spherical micro- and nanoparticles in nanomedicine , 2019, Materials Horizons.

[29]  Xuesi Chen,et al.  Immunomodulatory Nanosystems , 2019, Advanced science.

[30]  Yang Yang,et al.  Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines , 2019, Nature Communications.

[31]  J. Zink,et al.  Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery. , 2019, Accounts of chemical research.

[32]  L. DeLouise,et al.  Amorphous silicon dioxide nanoparticles modulate immune responses in a model of allergic contact dermatitis , 2019, Scientific Reports.

[33]  L. Wood,et al.  Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery , 2019, Front. Pharmacol..

[34]  Pawan Kumar,et al.  Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis , 2019, Front. Immunol..

[35]  T. Hyeon,et al.  Synergistic Oxygen Generation and Reactive Oxygen Species Scavenging by Manganese Ferrite/Ceria Co-decorated Nanoparticles for Rheumatoid Arthritis Treatment. , 2019, ACS nano.

[36]  M. Herrmann,et al.  Nanomaterial Exposure Induced Neutrophil Extracellular Traps: A New Target in Inflammation and Innate Immunity , 2019, Journal of immunology research.

[37]  J. Collier,et al.  Biomaterial interactions with the immune system. , 2019, Biomaterials science.

[38]  B. Fadeel Hide and Seek: Nanomaterial Interactions With the Immune System , 2019, Front. Immunol..

[39]  Fachao Zhi,et al.  A Molecular Targeted Immunotherapeutic Strategy for Ulcerative Colitis via Dual-targeting Nanoparticles Delivering miR-146b to Intestinal Macrophages , 2018, Journal of Crohn's & colitis.

[40]  Thanh Loc Nguyen,et al.  Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy , 2018, Advanced materials.

[41]  Sameh A. Korma,et al.  Liposome: composition, characterisation, preparation, and recent innovation in clinical applications , 2018, Journal of drug targeting.

[42]  O. Eniola-Adefeso,et al.  PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils. , 2018, Acta biomaterialia.

[43]  D. Mooney,et al.  Functional muscle recovery with nanoparticle-directed M2 macrophage polarization in mice , 2018, Proceedings of the National Academy of Sciences.

[44]  Rakeshchandra R. Meka,et al.  Peptide‐directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Junfeng Zhang,et al.  Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors. , 2018, Biomaterials.

[46]  P. Ma,et al.  Nanofibrous Spongy Microspheres To Distinctly Release miRNA and Growth Factors To Enrich Regulatory T Cells and Rescue Periodontal Bone Loss. , 2018, ACS nano.

[47]  B. Conti,et al.  Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting—In Vitro Evaluation , 2018, International journal of molecular sciences.

[48]  Steven J P McInnes,et al.  Murine and Non-Human Primate Dendritic Cell Targeting Nanoparticles for in Vivo Generation of Regulatory T-Cells. , 2018, ACS nano.

[49]  Priyanka Singh,et al.  Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer , 2018, International journal of molecular sciences.

[50]  J. Sibilia,et al.  Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression , 2018, Arthritis & rheumatology.

[51]  A. Zychlinsky,et al.  The role of neutrophil extracellular traps in rheumatic diseases , 2018, Nature Reviews Rheumatology.

[52]  P. Doerschuk,et al.  Self-assembly of highly symmetrical, ultrasmall inorganic cages directed by surfactant micelles , 2018, Nature.

[53]  M. Maggini,et al.  Biodistribution studies of ultrasmall silicon nanoparticles and carbon dots in experimental rats and tumor mice. , 2018, Nanoscale.

[54]  L. Bian,et al.  Magnetic Manipulation of Reversible Nanocaging Controls In Vivo Adhesion and Polarization of Macrophages. , 2018, ACS nano.

[55]  J. Di Domizio,et al.  Netting Neutrophils Activate Autoreactive B Cells in Lupus , 2018, The Journal of Immunology.

[56]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps: The Biology of Chromatin Externalization. , 2018, Developmental cell.

[57]  Roberto A. Maldonado,et al.  Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance , 2018, Front. Immunol..

[58]  X. Hou,et al.  Applications of silica-based nanoparticles for multimodal bioimaging , 2018 .

[59]  Xiaohua Wang,et al.  Polymer-Based Nanomaterials and Applications for Vaccines and Drugs , 2018, Polymers.

[60]  J. Crecente‐Campo,et al.  Modulating the immune system through nanotechnology. , 2017, Seminars in immunology.

[61]  R. Grandori,et al.  Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System. , 2017, Seminars in immunology.

[62]  F. Granucci,et al.  Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases. , 2017, Seminars in immunology.

[63]  J. Cabral,et al.  Nanocomposite capsules with directional, pulsed nanoparticle release , 2017, Science Advances.

[64]  E. A. Mills,et al.  Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment , 2017, Autoimmunity Highlights.

[65]  Joyce C Breger,et al.  Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[66]  P. Low,et al.  Folate-conjugated liposomes target and deliver therapeutics to immune cells in a rat model of rheumatoid arthritis. , 2017, Nanomedicine.

[67]  S. Muller,et al.  An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy. , 2017, Trends in pharmacological sciences.

[68]  Ying Zheng,et al.  Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics , 2017, Front. Pharmacol..

[69]  Kwangmeyung Kim,et al.  Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis. , 2017, Biomaterials.

[70]  Qinfu Zhao,et al.  A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics , 2017, Scientific Reports.

[71]  D. Maspoch,et al.  Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis. , 2017, Nanomedicine.

[72]  Arno C Gutleb,et al.  Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles. , 2017, ACS nano.

[73]  P. Kubes,et al.  An emerging role for neutrophil extracellular traps in noninfectious disease , 2017, Nature Medicine.

[74]  Nikolai G Khlebtsov,et al.  Immunological properties of gold nanoparticles , 2016, Chemical science.

[75]  J. M. Brauner,et al.  Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammation , 2016, Proceedings of the National Academy of Sciences.

[76]  F. Quintana,et al.  Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2 , 2016, Science Signaling.

[77]  Ronnie H. Fang,et al.  Nanoparticle-Based Modulation of the Immune System. , 2016, Annual review of chemical and biomolecular engineering.

[78]  G. Zampini,et al.  The Influence of Modified Silica Nanomaterials on Adult Stem Cell Culture , 2016, Nanomaterials.

[79]  Marina A Dobrovolskaia,et al.  Current understanding of interactions between nanoparticles and the immune system. , 2016, Toxicology and applied pharmacology.

[80]  P. Macchiarini,et al.  In vivo degeneration and the fate of inorganic nanoparticles. , 2016, Chemical Society reviews.

[81]  J. DeSimone,et al.  Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[82]  L. De Cola,et al.  Breakable mesoporous silica nanoparticles for targeted drug delivery. , 2016, Nanoscale.

[83]  Y. Barenholz,et al.  A liposomal steroid nano-drug for treating systemic lupus erythematosus , 2016, Lupus.

[84]  L. De Cola,et al.  Biodegradable Peptide-Silica Nanodonuts. , 2016, Chemistry.

[85]  Justin L. Brown,et al.  Polymeric nanoparticles: the future of nanomedicine. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[86]  I. Gonda,et al.  Development of Liposomal Ciprofloxacin to Treat Lung Infections , 2016, Pharmaceutics.

[87]  M. Radic,et al.  Oxidation and mitochondrial origin of NET DNA in the pathogenesis of lupus , 2016, Nature Medicine.

[88]  Susan Hua,et al.  Advances and Challenges of Liposome Assisted Drug Delivery , 2015, Front. Pharmacol..

[89]  Patrick J. Short,et al.  Towards programming immune tolerance through geometric manipulation of phosphatidylserine. , 2015, Biomaterials.

[90]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[91]  Roman Mathäs Non-spherical micro- and nanoparticles , 2015 .

[92]  S. Miller,et al.  Harnessing nanoparticles for immune modulation , 2015, Trends in Immunology.

[93]  M. Puig-Domingo,et al.  Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes , 2015, PloS one.

[94]  Samir Mitragotri,et al.  A Review of Clinical Translation of Inorganic Nanoparticles , 2015, The AAPS Journal.

[95]  M. Grzelczak,et al.  Glycans as biofunctional ligands for gold nanorods: stability and targeting in protein-rich media. , 2015, Journal of the American Chemical Society.

[96]  Roberto A. Maldonado,et al.  Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance , 2014, Proceedings of the National Academy of Sciences.

[97]  C. Löwik,et al.  Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[98]  V. Torchilin Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery , 2014, Nature Reviews Drug Discovery.

[99]  Renzo Boldorini,et al.  Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis. , 2014, Vaccine.

[100]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[101]  Bo Xiao,et al.  Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy. , 2013, Biomaterials.

[102]  U. Müller-Ladner,et al.  Current immunotherapy in rheumatoid arthritis. , 2013, Immunotherapy.

[103]  A. Lutterotti,et al.  Antigen-Specific Tolerance by Autologous Myelin Peptide–Coupled Cells: A Phase 1 Trial in Multiple Sclerosis , 2013, Science Translational Medicine.

[104]  X. Qu,et al.  Recent progress in nanosensors for sensitive detection of biomolecules. , 2013, Nanoscale.

[105]  Hyung J. Kim,et al.  Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles. , 2013, ACS nano.

[106]  C. Glass,et al.  Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013, Science.

[107]  Aaron J. Martin,et al.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis , 2012, Nature Biotechnology.

[108]  M. Radic,et al.  Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity , 2012, Journal of Immunology.

[109]  I. O. Wallinder,et al.  Hemolytic properties of synthetic nano- and porous silica particles: the effect of surface properties and the protection by the plasma corona. , 2012, Acta biomaterialia.

[110]  Y. Barenholz Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[111]  Srikanth K. Iyer,et al.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. , 2011, The Journal of clinical investigation.

[112]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[113]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[114]  Alfredo de la Escosura-Muñiz,et al.  Immunosensing using nanoparticles , 2010 .

[115]  Kinam Park To PEGylate or not to PEGylate, that is not the question. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[116]  S. Mutalik,et al.  Antigen-Specific Suppression of Inflammatory Arthritis Using Liposomes1 , 2009, The Journal of Immunology.

[117]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[118]  Samir Mitragotri,et al.  Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.

[119]  Endre J. Szili,et al.  Porous silicon biosensor for the detection of autoimmune diseases , 2007, SPIE Micro + Nano Materials, Devices, and Applications.

[120]  C. Niemeyer Functional devices from DNA and proteins , 2007 .

[121]  Vincent M Rotello,et al.  Functionalized gold nanoparticles for drug delivery. , 2007, Nanomedicine.

[122]  Weihong Tan,et al.  Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[123]  M. Wauben,et al.  Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. , 2003, Arthritis and rheumatism.

[124]  D. Chaplin Overview of the immune response. , 2003, The Journal of allergy and clinical immunology.

[125]  Khusru Asadullah,et al.  Mechanisms involved in the side effects of glucocorticoids. , 2002, Pharmacology & therapeutics.

[126]  J. Parkin,et al.  An overview of the immune system , 2001, The Lancet.

[127]  F. Brown,et al.  Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus. , 1995, Peptide research.

[128]  A. Saboury,et al.  Mesoporous silica nanoparticles for therapeutic/diagnostic applications. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[129]  Jordan J. Green,et al.  Polymeric micro- and nanoparticles for immune modulation. , 2018, Biomaterials science.

[130]  C. L. Ventola,et al.  Progress in Nanomedicine: Approved and Investigational Nanodrugs. , 2017, P & T : a peer-reviewed journal for formulary management.

[131]  S. Muller,et al.  Nanomaterials, Autophagy, and Lupus Disease , 2016, ChemMedChem.

[132]  M. Vicent,et al.  Polymer therapeutics-prospects for 21st century: the end of the beginning. , 2013, Advanced drug delivery reviews.

[133]  S. Miller,et al.  Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes. , 2012, The review of diabetic studies : RDS.

[134]  Samir Mitragotri,et al.  Shape Induced Inhibition of Phagocytosis of Polymer Particles , 2008, Pharmaceutical Research.

[135]  S. Muller,et al.  Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes. , 1994, Vaccine.